Connect with us


8-year-old COVID vaccines ‘Poster Boy’ dies of cardiac arrest



8-year-old COVID vaccines ‘Poster Boy’ dies of cardiac arrest
Spread The News

Eight-year-old Yonatan Moshe Erlichman, who was featured in a 2020 Israeli commercial promoting COVID-19 vaccinations for children, died last month of sudden cardiac arrest.

Yonatan Moshe Erlichman, the son and grandson of prominent Israeli doctors, almost drowned in the bathtub after his heart stopped on the eve of Yom Kippur. Although paramedics were able to revive him, he died several days later on Sept. 28.

In 2020, Erlichman appeared in a video with Shuski, described as a “friendly puppet ‘child,’” urging viewers to get the COVID-19 vaccine when it became available.

Erlichman’s tragedy mirrors the story of Santino Godoy Blanco, an Argentine boy who died last year at age 4 and who also was reported to have served as a national “poster boy” in advertisements promoting COVID-19 vaccines for children.

Blanco died of a lung infection associated with double pneumonia, which fact-checkers asserted was “unrelated with vaccination in general or COVID-19 vaccines in particular.”

READ ALSO: How CDC, others colluded to conceal side effects of COVID-vaccines—report

A tweet questioned why the story was not on televised news, but only in local and religious press. The person reported that the family was “scared to death and were trying to keep the story quiet.”

Israel is one of the most mRNA-vaccinated countries on Earth, with more than 70% of its people over 16 receiving at least two doses by April 2021.

In November 2020, Israel’s government signed an agreement with Pfizer to acquire 8 million doses of its COVID-19 vaccine, which the government began distributing in December 2020.

In exchange for receiving the vaccine ahead of other countries, Israel agreed to provide Pfizer with epidemiological data to help the vaccine maker evaluate the efficacy and reactogenicity of the vaccine.

In light of Erlichman’s death and echoing Hazan’s tweet, Dr. Robert Malone last week expressed concern that a combined genetic and medical database could aid the development of bioweapons capable of targeting specific ethnic groups.

He noted that “the engineered SARS-CoV-2 virus appears to be more severe with specific populations that have more ACE2 receptors on their cell surfaces” and asked, “Was this a bioweapon?”

READ ALSO: FDA finds ‘safety signal’ of seizures in children 2-5 after COVID mRNA vaccines

Information provided to Children’s Health Defense (CHD) last year by the Centers for Disease Control and Prevention (CDC) following a Freedom of Information Act request showed the CDC received a report in February 2021 about post-injection myocarditis from the Israel Ministry of Health.

The report stated, “We are seeing a large number of myocarditis and pericarditis cases in young individuals soon after the Pfizer COVID-19 vaccine. We would like to discuss the issue with a relevant expert at CDC.”

Even though a significant myocarditis safety signal was visible both in the U.S. and Israel just months after the COVID-19 vaccines were made available, the CDC failed to alert the public until May 2021, after half the eligible U.S. population had already received the vaccine.

In June 2021, Israel released an official report confirming mRNA-related myocarditis in young men, especially those ages 16-24, who showed a rate of up to 25 times higher than typically observed in the Hadassah Medical Center.

A September 2022 Israeli study found the incidence of myocarditis within 30 days of the second Pfizer shot was 2.35 times higher than in the unvaccinated, with the risk for males ages 16-19 presenting as nearly 1 in 1,000.

In June, CHD scientists called for an investigation into the CDC and the U.S. Food and Drug Administration for suppressing evidence linking the mRNA vaccines to myocarditis and pericarditis.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.